Literature DB >> 7702566

Adenylate cyclase, cyclic AMP and extracellular-signal-regulated kinase-2 in airway smooth muscle: modulation by protein kinase C and growth serum.

N Moughal1, P A Stevens, D Kong, S Pyne, N J Pyne.   

Abstract

Bradykinin and phorbol 12-myristate 13-acetate stimulate adenylate cyclase activity in serum-depleted cultured airway smooth muscle via a protein kinase C (PKC)-dependent pathway. The probable target is the type II adenylate cyclase, which can integrate coincident signals from both PKC and Gs. Therefore, activation of Gs (by cholera-toxin pre-treatment) amplified the bradykinin-stimulated cyclic AMP signal and concurrently attenuated the partial activation of extracellular-signal-regulated kinase-2 (ERK-2) by bradykinin. We have previously demonstrated that, in order to induce full activation of ERK-2 with bradykinin, it is necessary to obliterate PKC-stimulated cyclic AMP formation. We concluded that the cyclic AMP signal limits the magnitude of ERK-2 activation [Pyne, Moughal, Stevens, Tolan and Pyne (1994) Biochem. J. 304, 611-616]. The present study indicates that the bradykinin-stimulated ERK-2 pathway is entirely cyclic AMP-sensitive, and suggests that coincident signal detection by adenylate cyclase may be an important physiological route for the modulation of early mitogenic signalling. Furthermore, the direct inhibition of adenylate cyclase activity enables bradykinin to induce DNA synthesis, indicating that the PKC-dependent activation of adenylate cyclase limits entry of cells into the cell cycle. These studies suggest that the mitogenicity of an agonist may be governed, in part, by its ability to stimulate an inhibitory cyclic AMP signal pathway in the cell. The activation of adenylate cyclase by PKC appears to be downstream of phospholipase D. However, in cells that were maintained in growth serum (i.e. were not growth-arrested), bradykinin was unable to elicit a PKC-stimulated cyclic AMP response. The lesion in the signal-response coupling was not at the level of either the receptor or phospholipase D, which remain functionally operative and suggests modification occurs at either PKC or adenylate cyclase itself. These studies are discussed with respect to the cell signal regulation of mitogenesis in airway smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702566      PMCID: PMC1136581          DOI: 10.1042/bj3060723

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Cyclic AMP-dependent protein kinase from bovine heart muscle.

Authors:  C S Rubin; J Erlichman; O M Rosen
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

2.  Protein kinase C alpha activates RAF-1 by direct phosphorylation.

Authors:  W Kolch; G Heidecker; G Kochs; R Hummel; H Vahidi; H Mischak; G Finkenzeller; D Marmé; U R Rapp
Journal:  Nature       Date:  1993-07-15       Impact factor: 49.962

3.  Stimulation of phosphatidylcholine breakdown by thrombin and carbachol but not by tyrosine kinase receptor ligands in cells transfected with M1 muscarinic receptors. Rapid desensitization of phosphocholine-specific (PC) phospholipase D but sustained activity of PC-phospholipase C.

Authors:  F R McKenzie; K Seuwen; J Pouysségur
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

4.  Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate.

Authors:  J Wu; P Dent; T Jelinek; A Wolfman; M J Weber; T W Sturgill
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

5.  Protein kinase C-dependent cyclic AMP formation in airway smooth muscle: the role of type II adenylate cyclase and the blockade of extracellular-signal-regulated kinase-2 (ERK-2) activation.

Authors:  N J Pyne; N Moughal; P A Stevens; D Tolan; S Pyne
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

6.  Differential effects of B2 receptor antagonists upon bradykinin-stimulated phospholipase C and D in guinea-pig cultured tracheal smooth muscle.

Authors:  S Pyne; N J Pyne
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf.

Authors:  C A Lange-Carter; C M Pleiman; A M Gardner; K J Blumer; G L Johnson
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

8.  Bradykinin stimulates phospholipase D in primary cultures of guinea-pig tracheal smooth muscle.

Authors:  S Pyne; N J Pyne
Journal:  Biochem Pharmacol       Date:  1993-02-09       Impact factor: 5.858

Review 9.  Signalling properties of lysophosphatidic acid.

Authors:  M E Durieux; K R Lynch
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

10.  Stimulation of phosphatidate synthesis in endothelial cells in response to P2-receptor activation. Evidence for phospholipase C and phospholipase D involvement, phosphatidate and diacylglycerol interconversion and the role of protein kinase C.

Authors:  J R Purkiss; M R Boarder
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

View more
  2 in total

1.  Bradykinin stimulates cAMP synthesis via mitogen-activated protein kinase-dependent regulation of cytosolic phospholipase A2 and prostaglandin E2 release in airway smooth muscle.

Authors:  N J Pyne; D Tolan; S Pyne
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

2.  Protein kinase C-mediated enhancement of glycine response in rat sacral dorsal commissural neurones by serotonin.

Authors:  T L Xu; J Nabekura; N Akaike
Journal:  J Physiol       Date:  1996-10-15       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.